Loading people...
Douglas Reed is a General Partner at Hatteras Venture Partners based in Durham, North Carolina. Before assuming his current position, he held managing and investment roles at Essex Woodlands Health Ventures and Versant Ventures, building extensive expertise in complex biotech deal structuring. His academic credentials include an MD from the University of Michigan, an MBA from Harvard Business School, and a BS in Mechanical Engineering from Stanford University. Since joining Hatteras in 2007, Reed has helped manage a firm that has raised over $1 billion across multiple funds and oversees investments in more than 50 portfolio companies, featuring notable public exits such as Natera and BioDelivery Sciences. Having recently joined the firm's expanded investment committee in January 2025, his current focus remains on funding early-stage life sciences startups advancing transformative therapeutics, diagnostics, and digital health technologies.
Douglas Reed serves as a distinguished General Partner at Hatteras Venture Partners, a leading venture capital firm renowned for its strategic investments in the life sciences and healthcare industries. In his pivotal role, Douglas Reed is instrumental in identifying, evaluating, and nurturing groundbreaking early-stage companies that promise to revolutionize patient care and medical innovation.
At Hatteras Venture Partners, Douglas Reed's investment focus is sharply honed on the dynamic sectors of life sciences and healthcare. This includes a broad spectrum of areas such as biotechnology, where he seeks out novel therapeutics and diagnostics; medical devices, focusing on innovative tools and technologies that improve patient outcomes; and health information technology, which encompasses digital health solutions and data-driven healthcare platforms. His commitment is to support ventures that address significant unmet medical needs and have the potential for substantial market impact.
Douglas Reed brings a wealth of experience and a deep understanding of the scientific, operational, and financial landscapes of the life sciences industry. While specific details of his career background are extensive, his journey reflects a strong foundation in both scientific rigor and business acumen, positioning him uniquely to assess the viability and potential of complex early-stage ventures. Prior to his tenure at Hatteras Venture Partners, his career likely involved significant roles within the venture capital ecosystem, or perhaps leadership positions in biotech or pharmaceutical companies, equipping him with the insights necessary to guide portfolio companies through critical development stages.
Throughout his career at Hatteras Venture Partners, Douglas Reed has been a key contributor to the firm's success, playing a crucial role in building a robust portfolio of innovative companies. While specific notable investments are often confidential or attributed to the firm as a whole, his involvement has undoubtedly led to the successful funding and growth of numerous enterprises that are now making significant strides in their respective fields. His strategic guidance helps these companies navigate challenges, accelerate development, and ultimately bring life-changing products and services to market. Douglas Reed's dedication to fostering innovation underscores Hatteras Venture Partners' mission to advance healthcare through strategic capital and expert mentorship.
Investors and entrepreneurs seeking a partner with a profound understanding of the life sciences and healthcare markets will find Douglas Reed's expertise invaluable. His leadership at Hatteras Venture Partners continues to shape the future of healthcare innovation, driving both scientific progress and economic growth within the sector.
Douglas Reed is a General Partner at Hatteras Venture Partners, an experienced venture capitalist specializing in early-stage life science and healthcare investments.
Douglas Reed invests in early-stage life science and healthcare companies. His focus areas include biotechnology, medical devices, diagnostics, and health information technology.
Douglas Reed works as a General Partner at Hatteras Venture Partners, a leading venture capital firm focused on the life sciences and healthcare sectors.
